Making a case for del(1p) as a high-risk abnormality in multiple myeloma

被引：1
|
作者：
Schmidt, Timothy M. M. [1 ,2 ]
机构：
[1] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[2] 600 Highland Ave,K6-544 MC 5669 Clin Sci Ctr, Madison, WI 53792 USA
来源：
CANCER | 2023年 / 129卷 / 16期
关键词：
PROGNOSTIC-FACTOR; DELETIONS; THERAPY; CDKN2C; GENES; 1P;
D O I：
10.1002/cncr.34893
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2450 / 2452
页数：3
相关论文
共 50 条
  • [1] Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease
    Stork, Martin
    Ondrouskova, Eva
    Bohunova, Michaela
    Boichuk, Ivanna
    Fric, Dominik
    Adam, Zdenek
    Krejci, Marta
    Sandecka, Viera
    Knechtova, Zdenka
    Radova, Lenka
    Jelinkova, Zuzana
    Adlerova, Tatana
    Krticka, Milan
    Nekuda, Vladimir
    Borsky, Marek
    Sevcikova, Sabina
    Jarosova, Marie
    Pour, Ludek
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [2] Del(1p32): prime time in (ultra) high-risk myeloma
    Khot, Amit
    BLOOD, 2023, 141 (11) : 1241 - 1243
  • [3] Approach to High-Risk Multiple Myeloma
    Chen, Xiaoyi
    Varma, Gaurav
    Davies, Faith
    Morgan, Gareth
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 497 - 510
  • [4] 1p and 1q: Partners in crime in multiple myeloma
    Devarakonda, Srinivas S.
    Vaishnav, Arti
    Zhao, Qiuhong
    Bumma, Naresh
    Cottini, Francesca
    Sharma, Nidhi
    Umyarova, Elvira
    Rosko, Ashley Elizabeth
    Benson, Don M., Jr.
    Khan, Abdullah Mohammad
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Definition and therapy of high-risk Multiple Myeloma
    Willenbacher, W.
    Willenbacher, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 242 - 242
  • [6] Evolutionary biology of high-risk multiple myeloma
    Charlotte Pawlyn
    Gareth J. Morgan
    Nature Reviews Cancer, 2017, 17 : 543 - 556
  • [7] Understanding high-risk smoldering multiple myeloma
    Kreiniz, Natalia
    Gertz, Morie A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1361 - 1372
  • [8] Unifying the Definition of High-Risk in Multiple Myeloma
    Siegel, Ariel
    Boyle, Eileen M.
    Blaney, Patrick
    Wang, Yubao
    Ghamlouch, Hussein
    Choi, Jinyoung
    Caro, Jessica
    Williams, Louis
    Razzo, Beatrice
    Arbini, Arnaldo A.
    Braunstein, Marc
    Kaminetzky, David
    Auclair, Daniel
    Pawlyn, Charlotte
    Cairns, David
    Jackson, Graham
    Walker, Brian
    Bruno, Benedetto
    Morgan, Gareth J.
    Davies, Faith E.
    BLOOD, 2021, 138
  • [9] Evolutionary biology of high-risk multiple myeloma
    Pawlyn, Charlotte
    Morgan, Gareth J.
    NATURE REVIEWS CANCER, 2017, 17 (09) : 543 - 556
  • [10] Current Review on High-Risk Multiple Myeloma
    Chan, Henry S. H.
    Chen, Christine I.
    Reece, Donna E.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (02) : 96 - 108
12345